[O13] Muscular disease

Thu. May 31, 2018 1:30 PM - 2:40 PM Room 9 (1F 104)

Chair: Yasuhiro Takeshima(Department of Pediatrics, Hyogo College of Medicine), YUKA ISHIKAWA(Department of Pediatrics, National Organization Yakumo Hospital, Hokkaido, Japan)

+Add all to schedule

[O-067] The questionnaire survey about the process and the notice of diagnosis for the FCMD patient's family

Minobu Shichiji¹, KEIKO ISHIGAKI¹, TAKATOSHI SATO¹, MIZUSA MATSUDA², SATORU NAGATA¹ (1.The Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan, 2.The school of medicine, Tokyo Women's Medical University, Tokyo, Japan)

[O-068] Management of patients with FCMD on respiratory dysfunction and dysphagia

Michiko Makino, SHUUJI MATUI, KEIKO WADA, MASUKO FUNAHASHI, TOSHIHIDE SHIIKI (Department of Pediatrics,Tokyo Children's Rehabilitation Hospital,Tokyo,Japan)

[O-069] Modified gross motor function measure for Fukuyama congenital muscular dystrophy

Takatoshi Sato¹, MICHIRU ADACHI², MEGUMI HIROSE², MASAYA ZUSHI², KEISUKE GOTO², MOTOMICHI MASUYAMA², AYA MATSUO², KUMIKO ISHGURO¹, MINOBU SHICHIJI¹, TERUMI MURAKAMI¹, HUTOSHI WADA³, TETSUO IKAI³, IZUMI KONDO⁴, KEIKO ISHIGAKI¹, SATORU NAGATA¹ (1.Department of Pediatrics, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan, 2.Department of Rehabilitation, Tokyo Women's Medical University, Tokyo, Japan, 3.Department of Rehabilitation Medicine, School of Medicine, Tokyo Women's Medical University, Tokyo, Japan, 4.National Center for Geriatric Medicine and Gerontology)

[O-070] A Phase I, single— and repeated—dose study of TAS—205 in patients with Duchenne muscular dystrophy

Eri Takeshita¹, HIROFUMI KOMAKI^1,2, YUKO MOTOHASHI¹, AKIHIKO ISHIYAMA¹, KAZUHISA MIYOSHI³, IKUO YAMAMIYA³, NOBUKO YAMADA³, NAOKO MINAMI³ (1.Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 2.Department of Clinical Research Promotion, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 3.Taiho Pharmaceutical Co. Ltd.)

[O-071] Urinary titin is an accurate biomarker for Duchenne muscular dystrophy detection

Hiroyuki Awano¹, Masaaki Matsumoto¹, Masashi Nagai¹, Taku Shirakawa², Nobuhiro Maruyama³, Yo-ichi Nabeshima⁴, Masafumi Matsuo², Kazumoto Iijima¹ (1.Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan, 2.Department of Physical Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan, 3.Diagnostic and Research Reagents Division, Immuno-Biological Laboratories Co., Ltd., Fujioka, Japan, 4.Laboratory of Molecular Life Science Foundation for Biomedical Research and Innovation, Kobe, Japan)

[O-072] Single—institutional study of cardiac involvement in non—Duchenne／Becker muscular dystrophy

Hirokuni Yamazawa, Atsuhito Takeda, Gaku Izumi, Osamu Sasaki, Jiro Abe, Takanori Fujimoto (Department of Pediatrics, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan)

[O-073] Cardiac dysfunction is later in DMD patients with mutations in the dystrophin Dp116 coding region

Tetsushi Yamamoto¹, hiroyuki awano², masaaki matsumoto², masashi nagai², takamitsu imanishi¹, yuuji nakamachi¹, masafumi matsuo³, kazutomo iijima², jun saegusa¹ (1.Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan, 2.Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Japan, 3.Department of Physical Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan)